Galderma Research & Development

Sandrine Rethore

Pascal Collette

Cédric Poinsard

Pascale Mauvais

Jean-Michel Linget

Johannes Voegel

Carine Rosignoli

André Jomard

Philippe Andres

Itaru Suzuki

Philippe Martel

The use of compounds in the treatment of skin disorders is described. In particular, use of a compound of formula (I): or one of its pharmaceutically acceptable salts, solvates or hydrates in the preparation of a medicament to treat skin pathologies is described.

Phenol derivatives and the pharmaceutical or cosmetic use thereof

The present invention relates to novel compounds of general formula: and to the cosmetic or pharmaceutical use thereof.

Phenol derivatives and pharmaceutical or cosmetic use thereof

A combination of compounds is described for the treatment and/or prevention of skin conditions linked to hypopigmentation. Also described, is a combination product that includes at least one prostaglandin receptor agonist and at least one MC1R receptor agonist, as a medicament for use simultaneously, separately or spread out over time for the treatment and/or prevention of skin conditions linked to hypopigmentation, such as vitiligo.

Combination of a prostaglandin receptor agonist and an MC1R receptor agonist for the treatment and/or prevention of pigmentation disorders

Travoprost medicament compositions for non-daily topical application are useful for simulating or inducing the growth and/or decreasing the loss and/or increasing the density and/or reducing the heterogeneity in the diameter of human hair shafts/follicles, e.g., for the treatment of androgenic alopecia, such medicament compositions being at least twice applied over a time interval of greater than 24 hours.

Topical application of travoprost for combating hair loss

Growing community of inventors

Valbonne, France

Sandrine Rethore